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702ABSTRACT
Lung transplantation is a well-established treatment for selected patients with advanced
chronic respiratory insufﬁciency. Recognizing those patients with end-stage lung disease
who might beneﬁt from lung transplantation is a crucial task. Considering the presence of
inadequate evidence-based practice, international and national scientiﬁc societies
provided consensus opinions regarding the appropriate timing of listing. The Study
Group for Thoracic Organs Transplantation (branch of the Italian Society for Organs
Transplantation) promoted and realized a Delphi conference among the Italian lung
transplantation centers to provide guidance to clinical practice based on
international recommendations. The experts from the nine Italian centers completed two
rounds of standardized questionnaires (answer rate, 100%): 42 statements received a
consensus 80%. The selected statements presented in this article are intended to assist
Italian clinicians in selecting patients for lung transplantation.Study Group for Thoracic Organs Transplantation: E. Balestro
(Padua); A. Bertani (Palermo); M. Bofﬁni (Turin); A. Lucianetti
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Milan, Italy. E-mail: mario.nosotti@unimi.itLUNG transplantation (LT) is a valuable and worldwideaccepted treatment option for patients with end-stage
respiratory diseases who are refractory to conventional
therapies [1]. Despite the fact that the ﬁrst experimental
activities on animals date back to 1950 [2], LT has been
implemented in humans in Italy only since the early 1990s
with approximately 120e130 procedures per year currently
performed. Considering that the rate of LTs is roughly
2.2 per million inhabitants, the Italian National Trans-
plantation Centre has encouraged clinicians to develop
standard operating procedures to optimize the management
of these patients. One of the most important challenges
physicians working in a LT center encounter in
everyday clinical practice is the identiﬁcation of the proper
candidate for LT.
Over the past decade, international societies attempted to
deﬁne criteria for recipient selection. In light of the absence
of strong evidence, guidelines suggested a variety of criteria
and most of the recommendations are based on expert
opinions [3]. How the Italian scientiﬁc community has
accepted these recommendations and translated them into
clinical practice is unknown. It might be reasonable to7
.org/10.1016/j.transproceed.2017.02.026hypothesize a very heterogeneous approach in following
these recommendations across the country. One of the ﬁrst
challenges for the Italian community of surgeons and
pulmonologists taking care of LT patients would be to reach
a consensus on criteria for recipient selection published by
international societies.
The aim of this study was to use a modiﬁed Delphi
process among physicians working in nine Italian LT centers
to identify the level of agreement on criteria for recipient
selection recently suggested by international societies.ª 2017 The Author(s). Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1. General Principles for LT
Statements Consensus
LT is indicated in:
Patients with progressive respiratory failure despite
maximal medical therapy
100%
Patients with <50% of life expectancy at 2 y for their
respiratory failure
94.4%
Patients who have 80% chance of surviving 5 y after LT
provided that the graft will retain good function
88.9%
Patients who have 80% chance of surviving at 90 d
after LT
88.9%
The objective of the LT is to increase survival of the
patient with respiratory disease and to increase the
survival and/or quality of life of patients with
pulmonary emphysema
88.9%
Patients with pulmonary disease with poor quality of life,
intractable symptoms, and frequent hospital
admissions
83.3%
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This study was endorsed by the Italian Society for Pulmonology
(SIP/IRS) and the Italian Society for Thoracic Surgery (SICT). A
steering committee was proposed and approved by the Study Group
for Thoracic Organs Transplantation during the 39th National
Congress of the Italian Society for Organ Transplantation (SITO)
in 2015. The committee included one pulmonologist (O.T.), two
thoracic surgeons (N.M., D.D.), and one cardiothoracic surgeon
(D.A.) from different Italian geographic areas.
A review of the currently available literature was conducted on
PubMed. The search included articles published in English from
1985 to June 2016. The search included the following terms: “lung
transplantation candidates” OR “lung transplant candidates” OR
“recipient selection” AND “lung transplantation”. A total of 180
potentially relevant articles were identiﬁed and analysed by the
steering committee. Full texts were obtained for nine papers that
contained clear statements related to a general indication for
recipient selection [3e11]. The Committee was asked to draft a list
of these statements plus the national criteria for emergency LT.
A total of 67 statements were ﬁnally selected and split into six
separate sections, including general principles for listing, indications
and absolute contraindications for LT, relative contraindications for
LT, preoperative extracorporeal support, national emergency, and
retransplantation. The grading of scientiﬁc evidence and recom-
mendations was avoided to allow the expression of free judgment
during the conference.
The Committee contacted the nine Italian Lung Transplantation
centers to identify both pulmonologists and surgeons with greater
clinical experience in LT. A total of 18 clinicians (9 pulmonologists
and 9 surgeons) constituted the panel of experts who participated in
a modiﬁed Delphi process [12]. All of the process was carried out
anonymously. Experts were asked to grade each recommendation
using a 3-level scale (agreement, disagreement, or indifference).
Two rounds of voting were organized from July to October 2016.
Consensus was deﬁned as more than 80% agreement or disagree-
ment among the panel of experts. The ﬁrst round took place in July
2016; therefore, the anonymous ratings as well as comments were
tabulated. Statements for which consensus was not reached were
modiﬁed according to experts’ comments and underwent second-
round voting in September 2016. Results of both the ﬁrst- and
the second-round voting comprise the body of the present
consensus statement.RESULTS
All experts participated in both Delphi rounds; a ﬁnal
consensus among the experts was reached on 42 statements.
During the ﬁrst Delphi round, 40 statements received a
consensus with 80% of agreement, while none of the
statements reached 80% disagree consensus. The remaining
27 statements were reformulated according to experts’
comments. During the second Delphi round 2 more state-
ments reached consensus with more than 80% of
agreement.
General Principles for Listing
Experts agreed on the indication for LT in patients with
progressive respiratory failure despite maximal medical
therapy. The 3 general criteria expressed in the consensus
document from the International Society for Heart andLung Transplantation (ISHLT) received high consensus.
Two additional approved statements were related to
patients’ quality of life (Table 1).
Indications and Absolute Contraindications
A summary of statements regarding indications and
absolute contraindications for LT is presented in Table 2.
Consensus was achieved on the following items: patients
should be able to understand the risks for the procedure and
ﬁt enough to complete the preoperative examinations; age
limits were entrusted to physiological judgment; organ
insufﬁciency should be limited to the lung; coronary artery
disease with ventricular impairment is a contraindication
except in the case where an adequate revascularization is
possible and ventricular function is restorable; left ventric-
ular ejection fraction should be >45%; transplantation is
contraindicated in case of highly unstable medical condi-
tions, such as sepsis, myocardial infarction, and acute liver
failure, and in the case of uncorrectable bleeding diathesis;
LT is contraindicated in case of untreatable extrapulmonary
infections or Mycobacterium tuberculosis active infection;
transplantation is contraindicated in the case of a positive
history for malignancy in the last 5 years; transplantation
is contraindicated in case of chest wall deformity or pro-
gressive neuromuscular disorders; body mass index
(BMI) 35 kg/m2 is a contraindication; LT is contra-
indicated in the case of documented nonadherence to
treatment; transplantation is contraindicated in the case of
uncontrolled psychiatric disorders or absence of adequate
social support; transplantation is contraindicated when
adequate rehabilitation appears improbable; and, ﬁnally, LT
is contraindicated in the case of substance abuse.
Relative Contraindications
Statements regarding relative contraindications for LT are
presented in Table 3. Consensus was achieved on the
following matters: age limits, severe malnutrition and oste-
oporosis, colonization with highly resistant micro-organisms
Table 2. Indications and Absolute Contraindications
Statements Consensus
Basic conditions:
Patients should be able to understand the risks and
long-term implications of LT
100%
The patient should be able to undergo the clinical
investigations for enrollment on the waiting list
100%
Age:
The patient being considered for single LT must
demonstrate physiological age not >65 y
88.9%
The patient candidate for double LT must
demonstrate physiological age not >60 y
88.9%
Comorbidity:
LT is contraindicated in the case of severe
impairment of other organs (heart, kidney, liver,
and so on) except in patients who are candidates
for double transplantation
100%
LT is contraindicated in the case of coronary heart
disease with decreased ventricular function. The
treatment of coronary heart disease is allowed
provided it is effective, does not report sequelae,
and results in acceptable ventricular function.
100%
LT is contraindicated in the case of left ventricular
ejection fraction <45%
88.9%
LT is contraindicated in the case of the highly
unstable medical conditions, such as sepsis,
myocardial infarction, acute liver failure
88.9%
LT is contraindicated in the case of uncorrectable
bleeding diathesis
94.4%
Infection:
LT is contraindicated in the cases of untreatable
extrapulmonary infection
88.9%
LT is contraindicated in case of Mycobacterium
tuberculosis active infection
94.4%
Oncology:
LT is contraindicated in case of a positive history for
malignancy in the last 5 y (never in melanoma)
88.9%
Thoracic wall deformity:
LT is contraindicated in case of chest wall deformity
or progressive neuromuscular disorders
94.4%
BMI:
LT is contraindicated in case of BMI 35 kg/m2 100%
Compliance:
LT is contraindicated in the case of documented
nonadherence to treatment
100%
Psycho-social conditions:
LT is contraindicated in case of psychiatric disorders,
such as uncontrolled depression or psychosis
100%
LT is contraindicated in the case of absence of
adequate social support
83.3%
Rehabilitation:
LT is contraindicated when the general decline and
the muscle conditions of the patient raise serious
questions about the possibility of rehabilitation
after extubation
88.9%
Substance abuse:
LT is contraindicated in case of substance abuse.
The documented attendance at a special
rehabilitation program and the conﬁrmation of
serological samples of complete abstinence are
required.
100%
Table 3. Relative Contraindications
Statements Consensus
Age:
LT may be contraindicated in patients >65 y associated
with relative contraindications. Patients >75 y are
unlikely to be in the circumstances to overcome
transplantation.
94.4%
BMI:
LT may be contraindicated in the case of progressive
and severe malnutrition
94.4%
Bone metabolism:
LT may be contraindicated in patients with severe and
symptomatic osteoporosis
94.4%
Infection:
LT may be contraindicated in patients colonized with
highly resistant micro-organisms that would imply a
worsening in the postoperative course
94.4%
LT may be contraindicated in patients infected with
hepatitis C and B if the infection or cirrhosis are not
under control
100%
LT may be contraindicated in patients with HIV except in
cases of HIV-RNA not titratable, disease under
control, and demonstrated compliance to antiviral
therapy
88.9%
Comorbidity:
LT may be contraindicated in patients with
atherosclerosis. Patients treatable with percutaneous
coronary procedures can be treated and re-evaluated
for transplantation.
94.4%
LT may be contraindicated in patients suffering from
serious diseases that do not have adequate treatment
options or are not adequately controlled with medical
therapy
94.4%
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hepatitis C and B that are not under control and infection
with human immunodeﬁciency virus (HIV) except in cases
of HIV-RNA not titratable, disease under control, and
demonstrated compliance to antiviral therapy. LT may be
contraindicated in patients with atherosclerosis but patients
treatable with percutaneous coronary procedures can be
treated and re-evaluated for transplantation. Finally, LT
may be contraindicated in patients suffering from serious
diseases that do not have adequate treatment options.
Miscellanea
The experts approved six statements to manage extracor-
poreal support as a bridge to LT (Table 4). Statements were
related to the following points: indication to extracorporeal
support as bridge to LT is indicated in young patients,
without multiple organ dysfunctions and with a rehabilita-
tion potential; extracorporeal support should preferably be
maintained with conscious and autonomously breathing
patients; and, ﬁnally, severe occlusive atherosclerosis and
heparin-induced thrombocytopenia should be considered
contraindication to extracorporeal support.
Table 4 also shows statements for National Emergency
listing. The two approved sentences are related to the
Table 4. Miscellanea
Statements Consensus
Extracorporeal support as bridge to LT:
Extracorporeal support is indicated in young patients 88.9%
The extracorporeal support is indicated in patients
without multiple organ dysfunctions
94.4%
The extracorporeal support is indicated in patients with
rehabilitation potential
100%
Extracorporeal support should preferably be maintained
with conscious and autonomously breathing patients
88.9%
The extracorporeal support is not indicated in patients
with severe occlusive atherosclerosis
100%
The extracorporeal support is not indicated in patients
with heparin-induced thrombocytopenia
83.3%
National Emergency list:
The National Emergency list can be activated for
patients aged <50 y, with extracorporeal support
(excluding DECAP), on the waiting list, and admitted
to the intensive care unit of the transplantation center
100%
The National Emergency list cannot be activated for
patient with severe sepsis, multi-organ failure,
hemorrhagic shock, or neurological damage
100%
Retransplantation:
Lung retransplantation should be reserved for young
patients
94.4%
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years, with extracorporeal support (excluding DECAP);
and the patient must be on the waiting list and admitted to
the intensive care unit of the transplantation center. The list
cannot be activated for patient with severe sepsis, multi-
organ failure, hemorrhagic shock, or neurological damage.
In the end, Table 4 reports that consensus was reached on
the indication for lung retransplantation; such a procedure
should be reserved for young patients.DISCUSSION
Considering that LT is mainly limited by the scarcity of
suitable donor organs, recipient selection is crucial in a
national program for transplantation. This conference
meant to share opinions and homogenize general in-
dications and contraindications to LT across Italy. The
Delphi conference is a useful tool for evaluation and found
consensus among a board of experts with repeated rounds of
internet-based anonymous surveys [13]. The present project
involved 18 clinicians who represented the nine LT centers
in Italy. The response rate was 100% in both survey rounds
and this may be related to the strong interest from the
participating experts in this project.
There was full agreement among the expert panel on
the general principle that LT is indicated in patients with
progressive respiratory failure despite maximal medical
therapy. The three general criteria prompted by the ISHLT
in the 2014 consensus document also received a high
consensus from the Italian expert panel, despite some
concerns regarding the possibility to predict the percentage
of survival as required by those criteria [3].Age limit is a frequently debated issue among clinicians
taking care of LT patients. The panel approved a selection
of recipient according to a “physiological” age rather than a
rigid age limit. Conversely, the experts approved the ISHLT
age limit in the contest of the relative contraindications. A
complete consensus was reached on the absolute contrain-
dication to LT if the patient had a severe impairment of
other organs, except for patients who are candidates for
double transplantation. The experts agreed on the possi-
bility to treat the coronary syndrome to overcome the
contraindication related to ischemic heart disease.
Concerning oncological matters, the panel disagreed on
statements that favored a liberal approach and a limit of a
5-year disease-free interval after radical treatment for an
oncological disease was considered essential. The panel
expressed high consensus on absolute contraindication to
LT in patients with Mycobacterium tuberculosis active
infection or untreatable extrapulmonary infections; on the
contrary, highly resistant micro-organisms, hepatitis virus,
and HIV were quoted among relative contraindications.
Extracorporeal support as a bridge to LT found a
consistent consensus among the experts, establishing that
such rescue treatment must be offered to young patients
without extrapulmonary diseases; possibly, the support
should be maintained with conscious and autonomously
breathing patients. The panel reached total consensus with
the rules established for national emergency listing except
the limit on the duration of the emergency list (15 days)
and the upper and lower limits of BMI. Statements with
indications and limits for retransplantation received a very
low consensus except for the statement that such a pro-
cedure should be reserved for young patients.
In conclusion, the present Delphi conference represents a
collective agreement among 18 clinicians from the nine LT
centers in Italy. The recommendations outlined in this
document represent expert opinion, considering the pres-
ence of inadequate evidence-based practice. The selected
statements presented in this article are intended to assist
Italian clinicians in making the difﬁcult and weighty decision
to enlist a patient for LT. Nevertheless, operators should be
aware that, by their very nature, these statements cannot be
considered ﬁnal.REFERENCES
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